Trial to Confirm the Efficacy and Safety of Dasiglucagon in the Treatment of Hypoglycemia in T1DM Children
Status:
Completed
Trial end date:
2019-06-28
Target enrollment:
Participant gender:
Summary
A phase 3, randomized, double-blind, placebo- and active-controlled, parallel-arm trial to
assess the efficacy, safety, and pharmacokinetics of dasiglucagon relative to placebo and
GlucaGen® when administered as a rescue therapy for severe hypoglycemia in children with type
1 diabetes mellitus (T1DM) treated with insulin